Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis
Status:
COMPLETED
Trial end date:
2024-06-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the ease of use of the lebrikizumab pen. Participants will use a practice pad to simulate administration of a dose. Participants will complete the modified Subcutaneous Administration Assessment Questionnaire (mSQAAQ) following the simulated injection.
This study involves one study visit.